X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Elder Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ELDER PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ELDER PHARMA ALEMBIC LTD/
ELDER PHARMA
 
P/E (TTM) x 136.1 -0.2 - View Chart
P/BV x 5.1 0.1 5,009.9% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 ALEMBIC LTD   ELDER PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
ELDER PHARMA
Jun-14
ALEMBIC LTD/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs53380 13.9%   
Low Rs29188 15.6%   
Sales per share (Unadj.) Rs4.7491.2 1.0%  
Earnings per share (Unadj.) Rs8.8-3.2 -275.8%  
Cash flow per share (Unadj.) Rs9.014.4 62.5%  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.7376.5 7.4%  
Shares outstanding (eoy) m267.0320.54 1,300.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.70.6 1,504.3%   
Avg P/E ratio x4.7-89.3 -5.2%  
P/CF ratio (eoy) x4.619.7 23.1%  
Price / Book Value ratio x1.50.8 196.3%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,9625,833 187.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2382,179 10.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,26010,089 12.5%  
Other income Rs m264257 102.8%   
Total revenues Rs m1,52410,346 14.7%   
Gross profit Rs m83-792 -10.5%  
Depreciation Rs m61361 17.0%   
Interest Rs m02,756 0.0%   
Profit before tax Rs m285-3,653 -7.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-323,713 -0.9%   
Tax Rs m6125 4.9%   
Profit after tax Rs m2,343-65 -3,585.0%  
Gross profit margin %6.6-7.8 -83.7%  
Effective tax rate %2.1-3.4 -62.5%   
Net profit margin %185.9-0.6 -28,699.0%  
BALANCE SHEET DATA
Current assets Rs m1,6899,240 18.3%   
Current liabilities Rs m4869,998 4.9%   
Net working cap to sales %95.4-7.5 -1,270.6%  
Current ratio x3.50.9 375.8%  
Inventory Days Days21746 468.5%  
Debtors Days Days8160 135.2%  
Net fixed assets Rs m1,62410,124 16.0%   
Share capital Rs m534206 259.6%   
"Free" reserves Rs m5,9605,582 106.8%   
Net worth Rs m7,4047,734 95.7%   
Long term debt Rs m1044,889 2.1%   
Total assets Rs m8,01022,882 35.0%  
Interest coverage x950.7-0.3 -292,251.0%   
Debt to equity ratio x00.6 2.2%  
Sales to assets ratio x0.20.4 35.7%   
Return on assets %29.311.8 248.7%  
Return on equity %31.6-0.8 -3,744.6%  
Return on capital %31.322.3 140.2%  
Exports to sales %2.93.0 96.9%   
Imports to sales %28.90.4 6,755.1%   
Exports (fob) Rs m37307 12.1%   
Imports (cif) Rs m36443 843.8%   
Fx inflow Rs m37307 12.1%   
Fx outflow Rs m365125 291.3%   
Net fx Rs m-328181 -180.8%   
CASH FLOW
From Operations Rs m34611,754 2.9%  
From Investments Rs m-48-561 8.5%  
From Financial Activity Rs m-301-6,762 4.5%  
Net Cashflow Rs m-34,432 -0.1%  

Share Holding

Indian Promoters % 64.0 39.6 161.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 7.5 2.7%  
FIIs % 9.7 16.8 57.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 36.1 72.3%  
Shareholders   54,701 16,479 331.9%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  TTK HEALTHCARE  MERCK LTD  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Sensex Touching New Highs, Takeaways from Acquisition of HPCL and Top Stocks in Action Today(Pre-Open)

BSE Sensex is on a roll. The index touched a record high of 35,798 yesterday. Considering a span of one year, the benchmark index has delivered a 32% return.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jan 22, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - DR. REDDYS LAB COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS